Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Symposium on Signalling Pathways in Cancer 2017

DNA damage response: from cancer biology to oncology practice
Signalling Pathways 2017
Start date
17 Mar 2017
End date
18 Mar 2017
Sitges, Barcelona, Spain

The objective of the ESMO Symposium on Signalling Pathways in Cancer is to bring together basic scientists, academics, clinical researchers and industry researchers, medical and young oncologists with a special interest in the field in order to facilitate knowledge sharing through a series of interactive sessions and workshops.

The focus of the Symposium is on the preclinical and clinical issues relevant for targeting DNA damage response and the effect of systemic and radiation therapies.

The 5th Symposium – focusing on DNA damage response – was held in partnership with EACR.

ESMO Scientific Co-Chair

  • Ruth Plummer, Newcastle upon Tyne, UK

EACR Scientific Co-Chair

  • Eli Pikarsky, Jerusalem, Israel

Scientific Committee

  • Fortunato Ciardiello, Naples, Italy
  • Thomas Helleday, Stockholm, Sweden
  • Clare Isacke, London, UK
  • Jos Jonkers, Amsterdam, Netherlands
meeting resources


Webcasts from the meeting are online and can be accessed by ESMO members and event attendees

Programme 1000x250


The Signalling Pathways 2017 programme is now online!

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.